B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy aims to outsmart stubborn blood cancers
Disease control Not yet recruitingThis early-stage study tests a new type of CAR-T cell therapy (Sup19) in 9 adults with B-cell leukemia or lymphoma whose cancer either stopped responding to prior CD19-targeted treatments or has weak CD19 markers. The main goal is to check safety and find the right dose, while al…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New CAR-T therapy targets tough blood cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called BAFFR CAR-T for people with B-cell blood cancers (like certain leukemias and lymphomas) that did not get better or came back after standard treatments. The therapy uses a patient's own immune cells, modified to better find and a…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated May 22, 2026 14:04 UTC